{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T03:02:01Z","timestamp":1780023721177,"version":"3.53.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T00:00:00Z","timestamp":1776470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Clinical Research Innovation Plan of Shanghai General Hospital","award":["No. CCTR-2023C01"],"award-info":[{"award-number":["No. CCTR-2023C01"]}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["No. 82100683"],"award-info":[{"award-number":["No. 82100683"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Surg Onc"],"DOI":"10.1186\/s12957-026-04356-w","type":"journal-article","created":{"date-parts":[[2026,4,18]],"date-time":"2026-04-18T13:03:21Z","timestamp":1776517401000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Risk factor and prediction model for malignant pancreatic intraductal papillary mucinous neoplasm"],"prefix":"10.1186","volume":"24","author":[{"given":"Guo","family":"Yu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zihao","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxiao","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kena","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Wan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ge","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenqin","family":"Xiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,18]]},"reference":[{"issue":"10125","key":"4356_CR1","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S0140-6736(17)33326-3","volume":"391","author":"C Allemani","year":"2018","unstructured":"Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nik\u0161i\u0107 M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37\u2008513\u2008025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet. 2018;391(10125):1023\u201375.","journal-title":"Lancet"},{"issue":"11","key":"4356_CR2","doi-asserted-by":"publisher","first-page":"734","DOI":"10.1136\/jcp-2023-209012","volume":"76","author":"Y Omori","year":"2023","unstructured":"Omori Y, Furukawa T, Scarpa A, Luchini C. Co-occurring IPMN and pancreatic cancer: the same or different? An overview from histology to molecular pathology. J Clin Pathol. 2023;76(11):734\u20139.","journal-title":"J Clin Pathol"},{"issue":"4","key":"4356_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1136\/gut.2010.210567","volume":"60","author":"T Furukawa","year":"2011","unstructured":"Furukawa T, Hatori T, Fujita I, Yamamoto M, Kobayashi M, Ohike N, et al. Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas. Gut. 2011;60(4):509\u201316.","journal-title":"Gut"},{"issue":"8","key":"4356_CR4","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1007\/s00423-013-1106-1","volume":"398","author":"RM K\u00e4ppeli","year":"2013","unstructured":"K\u00e4ppeli RM, M\u00fcller SA, Hummel B, Kruse C, M\u00fcller P, Fornaro J, et al. IPMN: surgical treatment. Langenbecks Arch Surg. 2013;398(8):1029\u201337.","journal-title":"Langenbecks Arch Surg"},{"issue":"1\u20132","key":"4356_CR5","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1159\/000090023","volume":"6","author":"M Tanaka","year":"2006","unstructured":"Tanaka M, Chari S, Adsay V, Fernandez-del Castillo C, Falconi M, Shimizu M, et al. International consensus guidelines for management of intraductal papillary mucinous neoplasms and mucinous cystic neoplasms of the pancreas. Pancreatology. 2006;6(1\u20132):17\u201332.","journal-title":"Pancreatology"},{"issue":"5","key":"4356_CR6","doi-asserted-by":"publisher","first-page":"976","DOI":"10.1097\/SLA.0000000000000813","volume":"261","author":"G Marchegiani","year":"2015","unstructured":"Marchegiani G, Mino-Kenudson M, Sahora K, Morales-Oyarvide V, Thayer S, Ferrone C, et al. IPMN involving the main pancreatic duct: biology, epidemiology, and long-term outcomes following resection. Ann Surg. 2015;261(5):976\u201383.","journal-title":"Ann Surg"},{"issue":"1","key":"4356_CR7","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1186\/s12885-016-2887-8","volume":"16","author":"K Marsoner","year":"2016","unstructured":"Marsoner K, Haybaeck J, Csengeri D, Waha JE, Schagerl J, Langeder R, et al. Pancreatic resection for intraductal papillary mucinous neoplasm- a thirteen-year single center experience. BMC Cancer. 2016;16(1):844.","journal-title":"BMC Cancer"},{"issue":"3","key":"4356_CR8","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1016\/j.pan.2012.04.004","volume":"12","author":"M Tanaka","year":"2012","unstructured":"Tanaka M, Fern\u00e1ndez-del Castillo C, Adsay V, Chari S, Falconi M, Jang JY, et al. International consensus guidelines 2012 for the management of IPMN and MCN of the pancreas. Pancreatology. 2012;12(3):183\u201397.","journal-title":"Pancreatology"},{"issue":"6","key":"4356_CR9","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1111\/j.1477-2574.2009.00077.x","volume":"11","author":"JA Stauffer","year":"2009","unstructured":"Stauffer JA, Nguyen JH, Heckman MG, Grewal MS, Dougherty M, Gill KR, et al. Patient outcomes after total pancreatectomy: a single centre contemporary experience. HPB (Oxford). 2009;11(6):483\u201392.","journal-title":"HPB (Oxford)"},{"issue":"1","key":"4356_CR10","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1186\/s12893-019-0580-y","volume":"19","author":"E Buscail","year":"2019","unstructured":"Buscail E, Cauvin T, Fernandez B, Buscail C, Marty M, Lapuyade B, et al. Intraductal papillary mucinous neoplasms of the pancreas and European guidelines: importance of the surgery type in the decision-making process. BMC Surg. 2019;19(1):115.","journal-title":"BMC Surg"},{"issue":"1","key":"4356_CR11","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1097\/SLA.0000000000002015","volume":"267","author":"MA Attiyeh","year":"2018","unstructured":"Attiyeh MA, Fern\u00e1ndez-Del Castillo C, Al Efishat M, Eaton AA, G\u00f6nen M, Batts R, et al. Development and Validation of a Multi-institutional Preoperative Nomogram for Predicting Grade of Dysplasia in Intraductal Papillary Mucinous Neoplasms (IPMNs) of the Pancreas: A Report from The Pancreatic Surgery Consortium. Ann Surg. 2018;267(1):157\u201363.","journal-title":"Ann Surg"},{"issue":"1","key":"4356_CR12","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1097\/SLA.0000000000003108","volume":"272","author":"Y Shimizu","year":"2020","unstructured":"Shimizu Y, Hijioka S, Hirono S, Kin T, Ohtsuka T, Kanno A, et al. New Model for Predicting Malignancy in Patients With Intraductal Papillary Mucinous Neoplasm. Ann Surg. 2020;272(1):155\u201362.","journal-title":"Ann Surg"},{"issue":"2","key":"4356_CR13","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1097\/SLA.0000000000001988","volume":"266","author":"G Gemenetzis","year":"2017","unstructured":"Gemenetzis G, Bagante F, Griffin JF, Rezaee N, Javed AA, Manos LL, et al. Neutrophil-to-lymphocyte Ratio is a Predictive Marker for Invasive Malignancy in Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2017;266(2):339\u201345.","journal-title":"Ann Surg"},{"issue":"6","key":"4356_CR14","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/SLA.0000000000001985","volume":"266","author":"JY Jang","year":"2017","unstructured":"Jang JY, Park T, Lee S, Kim Y, Lee SY, Kim SW, et al. Proposed Nomogram Predicting the Individual Risk of Malignancy in the Patients With Branch Duct Type Intraductal Papillary Mucinous Neoplasms of the Pancreas. Ann Surg. 2017;266(6):1062\u20138.","journal-title":"Ann Surg"},{"issue":"11","key":"4356_CR15","doi-asserted-by":"publisher","first-page":"1043","DOI":"10.4251\/wjgo.v11.i11.1043","volume":"11","author":"J Hua","year":"2019","unstructured":"Hua J, Zhang B, Yang XJ, Zhang YY, Wei MY, Liang C, et al. Validation and head-to-head comparison of four models for predicting malignancy of intraductal papillary mucinous neoplasm of the pancreas: A study based on endoscopic ultrasound findings. World J Gastrointest Oncol. 2019;11(11):1043\u201353.","journal-title":"World J Gastrointest Oncol"},{"key":"4356_CR16","doi-asserted-by":"publisher","first-page":"1087852","DOI":"10.3389\/fonc.2023.1087852","volume":"13","author":"X He","year":"2023","unstructured":"He X, Fan R, Sun J, Ren Y, Zhao X, Rui W, et al. A model for predicting degree of malignancy in patients with intraductal papillary mucinous neoplasm. Front Oncol. 2023;13:1087852.","journal-title":"Front Oncol"},{"issue":"16","key":"4356_CR17","doi-asserted-by":"publisher","first-page":"16958","DOI":"10.1002\/cam4.6326","volume":"12","author":"X Huang","year":"2023","unstructured":"Huang X, Guo T, Zhang Z, Cai M, Guo X, Zhang J, et al. Prediction of malignant intraductal papillary mucinous neoplasm: A nomogram based on clinical information and radiological outcomes. Cancer Med. 2023;12(16):16958\u201371.","journal-title":"Cancer Med"},{"issue":"17","key":"4356_CR18","doi-asserted-by":"publisher","first-page":"e71182","DOI":"10.1002\/cam4.71182","volume":"14","author":"D Yang","year":"2025","unstructured":"Yang D, Liu X, Li M, Li Z, Ke N, Xiong J. Risk Factor and Prediction Model for Malignant Transformation in Pancreatic Intraductal Papillary Mucinous Neoplasm. Cancer Med. 2025;14(17):e71182.","journal-title":"Cancer Med"},{"issue":"2","key":"4356_CR19","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.pan.2023.12.009","volume":"24","author":"T Ohtsuka","year":"2024","unstructured":"Ohtsuka T, Fernandez-Del Castillo C, Furukawa T, Hijioka S, Jang JY, Lennon AM, et al. International evidence-based Kyoto guidelines for the management of intraductal papillary mucinous neoplasm of the pancreas. Pancreatology. 2024;24(2):255\u201370.","journal-title":"Pancreatology"},{"issue":"5","key":"4356_CR20","doi-asserted-by":"publisher","first-page":"789","DOI":"10.1136\/gutjnl-2018-316027","volume":"67","author":"European evidence-based","year":"2018","unstructured":"European evidence-based. guidelines on pancreatic cystic neoplasms. Gut. 2018;67(5):789\u2013804.","journal-title":"Gut"},{"issue":"1","key":"4356_CR21","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1016\/j.pan.2023.12.002","volume":"24","author":"E Ohno","year":"2024","unstructured":"Ohno E, Balduzzi A, Hijioka S, De Pastena M, Marchegiani G, Kato H, et al. Association of high-risk stigmata and worrisome features with advanced neoplasia in intraductal papillary mucinous neoplasms (IPMN): A systematic review. Pancreatology. 2024;24(1):48\u201361.","journal-title":"Pancreatology"},{"issue":"12","key":"4356_CR22","doi-asserted-by":"publisher","first-page":"2413","DOI":"10.1016\/j.cgh.2024.05.043","volume":"22","author":"T Hamada","year":"2024","unstructured":"Hamada T, Oyama H, Tange S, Hakuta R, Ishigaki K, Kanai S, et al. The Revised Kyoto Criteria and Risk of Malignancy Among Patients With Intraductal Papillary Mucinous Neoplasms. Clin Gastroenterol Hepatol. 2024;22(12):2413\u2013e2318.","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"2","key":"4356_CR23","doi-asserted-by":"publisher","first-page":"188409","DOI":"10.1016\/j.bbcan.2020.188409","volume":"1875","author":"G Luo","year":"2021","unstructured":"Luo G, Jin K, Deng S, Cheng H, Fan Z, Gong Y, et al. Roles of CA19-9 in pancreatic cancer: Biomarker, predictor and promoter. Biochim Biophys Acta Rev Cancer. 2021;1875(2):188409.","journal-title":"Biochim Biophys Acta Rev Cancer"},{"key":"4356_CR24","doi-asserted-by":"crossref","unstructured":"Nista EC, Schepis T, Candelli M, Giuli L, Pignataro G, Franceschi F et al. Humoral Predictors of Malignancy in IPMN: A Review of the Literature. Int J Mol Sci. 2021;22(23).","DOI":"10.3390\/ijms222312839"},{"issue":"2","key":"4356_CR25","doi-asserted-by":"publisher","first-page":"58","DOI":"10.4174\/astr.2019.97.2.58","volume":"97","author":"JS Kang","year":"2019","unstructured":"Kang JS, Park T, Han Y, Lee S, Lim H, Kim H, et al. Clinical validation of the 2017 international consensus guidelines on intraductal papillary mucinous neoplasm of the pancreas. Ann Surg Treat Res. 2019;97(2):58\u201364.","journal-title":"Ann Surg Treat Res"},{"issue":"9","key":"4356_CR26","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1002\/jhbp.275","volume":"22","author":"JR Kim","year":"2015","unstructured":"Kim JR, Jang JY, Kang MJ, Park T, Lee SY, Jung W, et al. Clinical implication of serum carcinoembryonic antigen and carbohydrate antigen 19\u2009\u2013\u20099 for the prediction of malignancy in intraductal papillary mucinous neoplasm of pancreas. J Hepatobiliary Pancreat Sci. 2015;22(9):699\u2013707.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"4","key":"4356_CR27","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.pan.2020.04.002","volume":"20","author":"D Ciprani","year":"2020","unstructured":"Ciprani D, Morales-Oyarvide V, Qadan M, Hank T, Weniger M, Harrison JM, et al. An elevated CA 19\u2009\u2013\u20099 is associated with invasive cancer and worse survival in IPMN. Pancreatology. 2020;20(4):729\u201335.","journal-title":"Pancreatology"},{"issue":"3","key":"4356_CR28","doi-asserted-by":"publisher","first-page":"466","DOI":"10.1097\/SLA.0b013e3182a18f48","volume":"258","author":"K Sahora","year":"2013","unstructured":"Sahora K, Mino-Kenudson M, Brugge W, Thayer SP, Ferrone CR, Sahani D, et al. Branch duct intraductal papillary mucinous neoplasms: does cyst size change the tip of the scale? A critical analysis of the revised international consensus guidelines in a large single-institutional series. Ann Surg. 2013;258(3):466\u201375.","journal-title":"Ann Surg"},{"issue":"2","key":"4356_CR29","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1097\/MPA.0b013e3181bab60e","volume":"39","author":"Y Sadakari","year":"2010","unstructured":"Sadakari Y, Ienaga J, Kobayashi K, Miyasaka Y, Takahata S, Nakamura M, et al. Cyst size indicates malignant transformation in branch duct intraductal papillary mucinous neoplasm of the pancreas without mural nodules. Pancreas. 2010;39(2):232\u20136.","journal-title":"Pancreas"},{"issue":"4","key":"4356_CR30","doi-asserted-by":"publisher","first-page":"580","DOI":"10.1177\/2050640615623370","volume":"4","author":"EP Robles","year":"2016","unstructured":"Robles EP, Maire F, Cros J, Vullierme MP, Rebours V, Sauvanet A, et al. Accuracy of 2012 International Consensus Guidelines for the prediction of malignancy of branch-duct intraductal papillary mucinous neoplasms of the pancreas. United Eur Gastroenterol J. 2016;4(4):580\u20136.","journal-title":"United Eur Gastroenterol J"},{"issue":"1","key":"4356_CR31","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1245\/s10434-007-9603-5","volume":"15","author":"JY Jang","year":"2008","unstructured":"Jang JY, Kim SW, Lee SE, Yang SH, Lee KU, Lee YJ, et al. Treatment guidelines for branch duct type intraductal papillary mucinous neoplasms of the pancreas: when can we operate or observe? Ann Surg Oncol. 2008;15(1):199\u2013205.","journal-title":"Ann Surg Oncol"},{"issue":"1","key":"4356_CR32","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1002\/jhbp.962","volume":"30","author":"HS Kim","year":"2023","unstructured":"Kim HS, Song W, Choo W, Lee S, Han Y, Bassi C, et al. Development, validation, and comparison of a nomogram based on radiologic findings for predicting malignancy in intraductal papillary mucinous neoplasms of the pancreas: An international multicenter study. J Hepatobiliary Pancreat Sci. 2023;30(1):133\u201343.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"4356_CR33","doi-asserted-by":"crossref","unstructured":"Yoon SJ, Kim H, Lee O, Jung JH, Lim CS, Shin YC et al. Development and external validation of a nomogram with inflammatory markers for predicting invasiveness of intraductal papillary mucinous neoplasm of pancreas. Med (Baltim). 2022;101(11).","DOI":"10.1097\/MD.0000000000029036"}],"container-title":["World Journal of Surgical Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12957-026-04356-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12957-026-04356-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T02:15:45Z","timestamp":1780020945000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12957-026-04356-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,18]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["4356"],"URL":"https:\/\/doi.org\/10.1186\/s12957-026-04356-w","relation":{},"ISSN":["1477-7819"],"issn-type":[{"value":"1477-7819","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,18]]},"assertion":[{"value":"22 January 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The studies involving human participants were reviewed and approved by Shanghai General Hospital Ethics Committee Shanghai Jiaotong University School of Medicine. Written informed consent for participation was not required for this study in accordance with the national legislation and the institutional requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"232"}}